Cargando…

The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer()

The Keap1-Nrf2 pathway is the major regulator of cytoprotective responses to oxidative and electrophilic stress. Although cell signaling pathways triggered by the transcription factor Nrf2 prevent cancer initiation and progression in normal and premalignant tissues, in fully malignant cells Nrf2 act...

Descripción completa

Detalles Bibliográficos
Autores principales: Kansanen, Emilia, Kuosmanen, Suvi M., Leinonen, Hanna, Levonen, Anna-Liisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757665/
https://www.ncbi.nlm.nih.gov/pubmed/24024136
http://dx.doi.org/10.1016/j.redox.2012.10.001
_version_ 1782282242375024640
author Kansanen, Emilia
Kuosmanen, Suvi M.
Leinonen, Hanna
Levonen, Anna-Liisa
author_facet Kansanen, Emilia
Kuosmanen, Suvi M.
Leinonen, Hanna
Levonen, Anna-Liisa
author_sort Kansanen, Emilia
collection PubMed
description The Keap1-Nrf2 pathway is the major regulator of cytoprotective responses to oxidative and electrophilic stress. Although cell signaling pathways triggered by the transcription factor Nrf2 prevent cancer initiation and progression in normal and premalignant tissues, in fully malignant cells Nrf2 activity provides growth advantage by increasing cancer chemoresistance and enhancing tumor cell growth. In this graphical review, we provide an overview of the Keap1-Nrf2 pathway and its dysregulation in cancer cells. We also briefly summarize the consequences of constitutive Nrf2 activation in cancer cells and how this can be exploited in cancer gene therapy.
format Online
Article
Text
id pubmed-3757665
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-37576652013-09-10 The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer() Kansanen, Emilia Kuosmanen, Suvi M. Leinonen, Hanna Levonen, Anna-Liisa Redox Biol Review Article The Keap1-Nrf2 pathway is the major regulator of cytoprotective responses to oxidative and electrophilic stress. Although cell signaling pathways triggered by the transcription factor Nrf2 prevent cancer initiation and progression in normal and premalignant tissues, in fully malignant cells Nrf2 activity provides growth advantage by increasing cancer chemoresistance and enhancing tumor cell growth. In this graphical review, we provide an overview of the Keap1-Nrf2 pathway and its dysregulation in cancer cells. We also briefly summarize the consequences of constitutive Nrf2 activation in cancer cells and how this can be exploited in cancer gene therapy. Elsevier 2013-01-18 /pmc/articles/PMC3757665/ /pubmed/24024136 http://dx.doi.org/10.1016/j.redox.2012.10.001 Text en © 2013 The Authors http://creativecommons.org/licenses/BY-license/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review Article
Kansanen, Emilia
Kuosmanen, Suvi M.
Leinonen, Hanna
Levonen, Anna-Liisa
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer()
title The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer()
title_full The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer()
title_fullStr The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer()
title_full_unstemmed The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer()
title_short The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer()
title_sort keap1-nrf2 pathway: mechanisms of activation and dysregulation in cancer()
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757665/
https://www.ncbi.nlm.nih.gov/pubmed/24024136
http://dx.doi.org/10.1016/j.redox.2012.10.001
work_keys_str_mv AT kansanenemilia thekeap1nrf2pathwaymechanismsofactivationanddysregulationincancer
AT kuosmanensuvim thekeap1nrf2pathwaymechanismsofactivationanddysregulationincancer
AT leinonenhanna thekeap1nrf2pathwaymechanismsofactivationanddysregulationincancer
AT levonenannaliisa thekeap1nrf2pathwaymechanismsofactivationanddysregulationincancer
AT kansanenemilia keap1nrf2pathwaymechanismsofactivationanddysregulationincancer
AT kuosmanensuvim keap1nrf2pathwaymechanismsofactivationanddysregulationincancer
AT leinonenhanna keap1nrf2pathwaymechanismsofactivationanddysregulationincancer
AT levonenannaliisa keap1nrf2pathwaymechanismsofactivationanddysregulationincancer